Press Kit: 2026 Multidisciplinary Head and Neck Cancers Symposium
The 2026 Multidisciplinary Head and Neck Cancers Symposium will take place February 19-21 in Palm Desert, California. This two-and-a-half-day meeting for the specialists who treat patients with head and neck cancers provides the most up-to-date research and education on multidisciplinary treatment advances and clinical care.
The symposium is cosponsored by the American Society for Radiation Oncology (ASTRO), the American Head & Neck Society (AHNS), the American Society of Clinical Oncology (ASCO) and the Society for Immunotherapy of Cancer (SITC).
Embargo Policy and Access to Abstracts
All abstracts to be presented at the 2026 Multidisciplinary Head and Neck Cancers Symposium are embargoed until 8:00 a.m. Pacific time, Thursday, February 19, 2026. The embargo policy applies to all abstracts regardless of whether information is obtained from another source.
Embargo violations by media professionals may result in suspension of credentials at the symposium as well as future meetings and may also impact the ability to receive advance media materials for future meetings. Embargo violations by abstract authors and/or sponsors may result in removal of the abstract from the scientific program. Abstract authors are responsible for notifying financial and other sponsors about this embargo policy.
The full text of the abstracts selected for oral and poster presentation will be available online at the start of the meeting. Abstracts also will be published in a supplement of the International Journal of Radiation Oncology • Biology • Physics.
Press Registration
Contact ASTRO’s media relations team to request press registration.
ASTRO provides complimentary meeting registration to credentialed news professionals representing media organizations for the express purpose of gathering news and information to produce editorial coverage of the symposium. Applicants may be asked to provide media credentials, a letter of assignment and/or bylined articles.
Complimentary registration is also open to public information officers from educational institutions, government agencies and nonprofit cancer research organizations presenting research at the symposium. Exhibitors are not permitted to register as press unless they can provide proof of editorial assignment from an accredited news organization that meets the above criteria. Public relations, marketing and/or advertising representatives, financial analysts, book publishers and book authors, and individuals from communications, print or online promotion services are welcome to register as regular attendees, however, they are not permitted to register as press. ASTRO reserves the right to bar from this and future meetings any journalist who misuses press privileges to engage in activities other than journalistic pursuits.
For More Information
ASTRO’s media relations team is available to help with media inquiries or interview requests.
For details about the meeting, visit the symposium website.
Connect with ASTRO on social media.
Find patient information at RTAnswers.org.
